Abstract
The relationship between quality of care and provider’s experience is well known in all fields of surgery. Even in thyroidectomies and parathyroidectomies, the emphasis on positive volume-outcome relationships is believed. It led us to an evaluation of volume activity’s impact in terms of quality of care.
A systematic narrative review was performed. According to the PRISMA criteria, we selected 87 paper and, after the study selection was performed, 22 studies were finally included in this review.
All articles included were unanimous in attributing to activity volume of surgeons as well as centers a substantial importance. Some differences in outcomes between these investigated categories have been found: best results of the high volume surgeon is evident expecially in terms of complications, on the contrary best outcomes of a high volume center are mainly economics, such as hospital stay and general costs of the procedures.
A cut-off of 35–40 thyroidectomies per year for single surgeon, and 90–100 thyroidectomies for single center appears reasonable for identifying an adequate activity. Concerning parathyroidectomy, we can consider reasonable a cut off at 10–12 operations/year. More studies are needed in a European or more circumscribed perspective.
Keywords: Thyroidectomy, Parathyroidectomy, High volume surgeon, High volume hospital
Introduction
The strict relationship between quality of care and provider’s experience was underlined until late 1970 by Luft et al. (1). Nowadays Endocrine Surgery is a distinct sub-specialty of general surgery dedicated to surgical treatment of thyroid, parathyroid and adrenal glands’ disease and gastrointestinal and pancreatic neuroendocrine tumors. The advantages given from the sub-specialisation of a surgeon and/or a center are commonly accepted and a number of manuscripts concerning this aspect have been published in the last decade (2–5). Since the improving in outcomes of high volume hospitals and surgeons was demonstrated in several studies, there is a worldwide trend towards a centralization of endocrine surgery procedures (4). The surgeons who had a specific interest for the surgical treatment of endocrine disorders founded the American Association of Endocrine Surgeons [AAES] in the early eighties. Since then, during the decades, several national and continental endocrine surgery societies were born (6–10). Some societies, such as AAES, created a fellowship for improving a specific training. At the same time, the European Union of Medical Specialists has arranged certification examinations in ES and, more recently, in Endocrine Neck Surgery (ENS) (11). Despite all these efforts in improving the training of Endocrine Surgeons, their real advantage is still unknown, anyway the emphasis on positive volume-outcome relationships is widely believed. It led us to an evaluation of volume activity’s impact in terms of quality of care.
The aim of present review is to fix how many procedures are necessary for achieving optimal results in ENS (thyroid and parathyroid) and which specific outcomes are influenced by a high volume surgeon and hospital.
Methods
The systematic narrative review of the present manuscript is fully compliant with PRISMA criteria (12). According to these guidelines, the selection of the studies included in the present review has been conducted as follow.
Literature search strategy
An electronic literature review was performed on MEDLINE by using the medical subject headings (MESH) “high volume”, “endocrine surgery” with the Boolean operator and. Three independent investigators (GM, CP, and RG) performed this research. The publications in English language of the past fifteen years were systematically included but the commonly referenced and/or highly regarded older publications were also considered. We also searched reference lists of articles identified by this search strategy and selected those we judged relevant.
Selection criteria
We took into consideration clinical trials, reviews and meta-analyses that investigate about surgeon and hospital volume, hospital costs, length of stay, survival as regards as thyroid(ectomy) and parathyroid( ectomy).
Study selection
Eighty-nine papers were found according to this search strategy.
In the first stage, all titles and abstracts were read and selected according the mentioned selection criteria, and 16 abstracts were then excluded. Seventy-three articles were selected for further reading. We excluded 45 papers that did not meet quality criteria or evaluated a too small sample.
In this second stage, some full text was also obtained for relevant papers, as well as any citations for which a decision could not be made from the abstract.
Final decision regarding inclusion were based after reading full article and 28 papers was considered eligible for this review. Finally, 22 articles were selected.
We did not perform a metanalysis of the collected data due to extreme variability of the samples, methods of data collection, subjects investigated and outcomes evaluated.
The search process was performed as in Figure 1.
Figure 1.
Search process.
Results
Among articles included in this review, surgical interventions/year threshold needed for reaching good outcomes in endocrine surgery procedures varies in accordance with the type of procedure (thyroidectomy, parathyroidectomy). Moreover, the cut-off to identify high volume surgeons differ from those stated for high volume centers. In these articles, we also found differences in outcomes (complications, costs, appropriateness or completeness of the procedure performed, recurrence rate). Concerning thyroidectomy, this cut-off ranges from ≥23 thyroidectomies/year per surgeon to ≥100 (13–16) thyroidectomies per surgeon. Some authors adjusted surgeon’s volume per case-mix and calculated volume across a fixed period (6 years) (17). Minimum hospital volume needed for reaching a satisfying level of safety is less clear and ranges from 50 and 200 procedures per year (4, 18). These boundaries appear arbitrary, although reasonable, in some cases (14, 16). In other papers, it was stated on the basis of the number of thyroidectomies performed per year, as mean of cases number performed each year for each individual surgeon, for these years in which that surgeon performed at least one thyroid surgery procedure. (13, 15). A study recently published from Al-Qurayshi and coll. was led on the basis of American inpatients database sample (NIS) that involves about 8 million of hospital stays of around 1000 hospitals as a sample representative of 20% of community hospital in USA. Then, over 77.000 discharges corresponding to DRGs concerning the thyroid surgery were involved. On the basis of thyroidectomies performed per each year, surgeons were classified into low-volume (≤ 25th percentile: 1–3 thyroidectomies per year), intermediate volume (from 26th to ≤ 75th percentile, 4–29 thyroidectomies per year) and high volume (> 75th percentile, 30 or more thyroidectomies per year). Several potential biases, such as sex, race, age, socioeconomic characteristic, payers of health care services, obesity and other comorbidities, extent of surgical operation (unilateral, bilateral, neck dissection) hospital characteristics were also taken into account. This study showed that the complications’ rate and even costs decrease significantly if the thyroid surgery is performed by higher volume surgeons (19). Adam et al. (20) used a multivariate logistic regression model with restricted cubic splines (RCS) to estimate the association between annual surgeon volume and incidence of the complications. This statistic model draws a flexible function with robust behaviour at the tails of predictor distributions. The use of this model was aimed to fix the range of annual surgeon volumes corresponding to a change in the relative log odds of experiencing any postoperative complication. This is the first study in which a statistical method has been used for establish activity volume threshold that resulted in 26 or more cases per year (21). In a study conducted at the Kaiser Permanente Northern California and Kaiser Permanente Southern California regions, nearly 200 surgeons that operated more than 15.000 patients from 2008 to 2013 for thyroid diseases were involved. Surgeons were categorized at first into three groups (low, intermediate and high volume) because of the dubiousness in providing exactly the cut-off between low and high-volume. Then, surgeons’ allocation in a specific group were done by creating similar volumes of patients as much as possible. The three resulting groups were low-volume (≤ 20 procedures per year), intermediate volume (21–40) and high volume surgeons (> 40 procedures per year). Afterwards, only patients operated by low and high volume surgeons were taken into consideration, and then matched for avoiding biases linked to differences between two series. The study showed advantages in favour of high volume surgeons in terms of length of surgery, length of stay, outpatient procedures rate and 30-days all cause readmission rate, but no significant changes in terms of specific complications (22). Only a few studies have been done outside the USA: in a systematic review and meta-analysis conducted in Taiwan, annual surgeon volume was categorized into dichotomous variable that were set by dividing the whole study population in two halves. Therefore, the exact cut-off were determined each study year, steadying around 70 cases per year. This study showed significant advantages of the high volume surgeon’s group in terms of costs, length of stay but not in mortality rate (23). In a study from Nouraei et al., surgeon volume was calculated by dividing total number of thyroidectomies performed by an individual surgeon and number of years of specific activity. So, low volume (<10 thyroidectomies per year) and high volume surgeons (>50 thyroidectomies per year) categories were compared in a study involving more than 72.000 procedures performed between 2004 and 2012. Even in this study, patients’ advantages operated by high volume surgeons were evident in terms of complication’s rate and length of stay (24). One more study involving more than 147.000 patients from 2000 to 2009 concerned specifically neck hematoma following thyroid and parathyroid surgery. In this study, surgeons were classified into three categories and the advantages of high volume surgeons (100 or more thyroidectomies) were significant in comparison with low-volume ones (<10 procedures per year) (25). In a study focused on thyroid carcinoma outcomes, Adkisson et al. grouped surgeons into narrow thresholds of thyroidectomies per year: 10, 20, 25, 30, 50 and 100. Surgeons performing more than 30 thyroidectomies per year had better results in terms of completeness of surgical resection (≥ 50 cases/year for advanced cases) (26). Another study compared two groups of surgeons, general versus endocrine surgeons working in the same institution, in terms of surgeon’s age, volume, years of practice, specialized training in neck endocrine surgery on postoperative complications (permanent RLN palsy and permanent hypocalcaemia). The study showed that high volume surgeons, performing > 40 procedures per year, have a lower incidence of postoperative complications such as vocal fold palsy and hypocalcaemia compared to general surgeons, performing 5 thyroidectomies per year. Moreover, surgical operations performed in each center resulted more complex in endocrine surgeons group that performed 19,5% of thyroidectomies and neck dissections, compared to none neck dissection of general surgeons group. The study also showed that surgeons aged between 35 and 50 years had better performances compared to younger or older colleagues; however, it was not able to define exactly the threshold of procedures needed for achieving optimal results. This exact minimum, defining a high volume surgeon, remains unknown (27). The cut-off values for hospital volume do not change in method of definition among the various studies examined compared with the methods for fixing the surgeon’s volume ones. Most of the studies that focused advantages of high volume centers in reaching better results in thyroid surgery highlighted, in particular, an increased incidence of total thyroidectomy, case complexity, and cancer diagnoses (5, 14), a reduced incidence in avoidable reoperations (18), length of stay (23) and need in radioiodine ablative treatment (28). Table 1 summarizes the most relevant studies cited. Briefly, outcomes clearly connected with the hospital volume are mainly economic and managerial (hospital stay, costs). Moreover, a high volume center seem to be more performant in front of complex cases (completeness, reoperations, need of radioiodine ablative treatment). A high volume surgeon seems to be safer, promising a reduced incidence of complications. Concerning threshold for defining a high volume surgeon or centre, in the lack of consensus among the studies taken into consideration, it seems reasonable to fix them in >40–50 and >100–150 respectively for surgeon and hospital. Of course, high volume surgeon’s performance should be considered in 7–10 years, whereas hospital volume should match surroundings specialties, such as endocrinology, Nuclear Medicine, Radiology in which a service of CT and NMRI is available, Oncology, ORL, ICU and, at least a network in which a thoracic surgery and more specialistic services are available (29).
Table 1.
HIGH VOLUME THYROID SURGEONS AND HOSPITALS: CUT-OFF AND OUTCOMES.
Author | Patients | HVS | HVC | Outcomes |
---|---|---|---|---|
Mitchell, 2008 | 189 redo surgeries | - | 81 | Reoperations |
Lifante, 2009 | >20.000 | - | ≥100 | Hospital stay Surgery completeness |
Gourin, 2010 | >21.000 | >24 | >100 | Surgeons: complications Hospitals: completeness complexity |
Schuessler, 2013 | 589 Hospitals | - | >35 | Need of radioiodine treatment in cancer |
Gonzàlez-Sànchez, 2013 | 225 | >40 | - | Complications Surgical complexity |
Dehal, 2014 | 147.000 | ≥100 | - | Neck hematoma |
Adkisson, 2014 | 1249 | >30 | - | Resection completeness (thyroid cancers) |
Adam, 2016 | >16.000 | ≥26 | - | Complications |
Meltzer, 2016 | >15.000 | >40 | - | Lenght surgery/stay, Readmission, Outpatient |
Al-Qurayshi, 2016 | >77.000 | >30 | - | Complications/Costs |
Liang, 2016 | >62.000 | >70 | >200 | Lenght stay Costs Mortality |
Nouraei, 2017 | >72.000 | >50 | - | Vocal fold palsy Lenght of stay |
Beyond thyroidectomy, parathyroid surgery needs a skilled team for managing cases frequently complex, from initial diagnosis to postoperative follow-up. We found very few studies that specifically concerned parathyroid surgery. High volume thyroid surgeons and centers seem to influence favourably parathyroid surgery results (18). Abdulla et al. categorized hospital volume into five groups, corresponding to rough quintiles: very low (1–4 procedures per year), low (5–9), medium (10–19), high (20–49), and very high (≥50). Complications rates (neck hematoma, vocal fold palsy, hypocalcemia) and reoperations decreased in high volume centers, so a realistic target caseload of around 15 cases annually was recommended (30) according to other studies (31). These papers are summarized in Table 2. We are convinced that a skill in endocrine neck surgery is a useful common ground for improving both thyroid and parathyroid surgery results.
Table 2.
HIGH VOLUME PARATHYROID HOSPITALS: CUT-OFF AND OUTCOMES.
Author | Patients | Cut-off | Outcomes |
---|---|---|---|
Mitchell, 2008 | 335 | ? | Avoidable reoperations |
Yeh, 2011 | 1190 | 15 | Persistence |
Abdulla, 2015 | 17.082 | 10–20 | Complications Reoperations |
Discussion
Results of endocrine neck surgical procedures depend on several factors most of whom (talent of the surgeon, hospital efficiency) are only supposable but not easily assessable. Moreover, only few papers included in this review came from Europe (14, 27), and any of these from Italy. This factor could influence somehow results.
In our personal experience, we observed a decrease of complications during the years of surgical practice (32–38) and slight and momentary new increase after the introduction of new techniques (39, 40), anyway non-significant, and, in the most part of the cases, introduction of new devices led us to a general improvement of results (41, 42). Moreover, some sequelae of thyroid and parathyroid surgery (swallowing and voice complaints, chronic asthenia) are not related to specific procedure complications, but based on specific pathophysiologic mechanisms (43–46). In times of spending review, the indicators of quality are strongly put under observation. In this perspective, a value-based health care delivery system is needed for improving outcomes reducing, at the same time, costs. This could require an increasing in volume that could lead to a subspecialty surgical service (47). In the present review, all articles we looked up are unanimous in attributing to activity volume of surgeons as well as centers a substantial importance. Some differences in outcomes between these investigated categories have been found: best results of the high volume surgeon is evident expecially in terms of complications, on the contrary best outcomes of high volume centers are mainly economics (hospital stay, general costs of the procedures) (4, 5, 14, 22).
Conclusions
Establishing some criteria to identify high volume surgeon and high volume center is a real need considering three main exigencies of the health delivery system, such as limiting medicolegal claims, reducing costs and improving results. These results can be reached only by specific surgical expertise and a consequent increase in competence of consulting units, first endocrinology unit but also radiology, nuclear medicine, cytopathology, oncology and any specialist involved in care process. A minimum volume of 35–40 thyroidectomies per year for single surgeon, and 90–100 thyroidectomies for single center appears a reasonable cut off for identifying an adequate activity. Concerning parathyroidectomy, which should be performed in high volume hospital for thyroidectomy, we can consider reasonable a cut off at 10–12 operations/year.
More studies developed in different European countries are needed for evaluating if local health delivery systems allow reaching an acceptable performance and if some suggestions could be useful for improving the specific results.
References
- 1.Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? N Engl J Med. 1979;301(25):1364–9. doi: 10.1056/NEJM197912203012503. [DOI] [PubMed] [Google Scholar]
- 2.Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery. 2007;142(6):887–99. doi: 10.1016/j.surg.2007.09.003. [DOI] [PubMed] [Google Scholar]
- 3.Krishnamurthy VD, Jin J, Siperstein A, Shin JJ. Mapping endocrine surgery: Workforce analysis from the last six decades. Surgery. 2016;59(1):102–12. doi: 10.1016/j.surg.2015.08.024. [DOI] [PubMed] [Google Scholar]
- 4.Liang TJ, Liu SI, Mok KT, Shi HY. Associations of Volume and Thyroidectomy Outcomes: A Nationwide Study with Systematic Review and Meta-Analysis Otolaryngol. Head Neck Surg. 2016;155(1):65–75. doi: 10.1177/0194599816634627. [DOI] [PubMed] [Google Scholar]
- 5.Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM, Bristow RE. Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg. 2010;136:1191–1198. doi: 10.1001/archoto.2010.212. [DOI] [PubMed] [Google Scholar]
- 6.http//www.endocrinesurgery.org
- 7.http//www.chirurgie-endocrinienne.net
- 8.http//www.eses.cc
- 9.http//www.siecitalia.eu
- 10.http//www.baets.org.uk
- 11.http//www.uemssurg.org
- 12.Moher D, Liberati A, Tetzlaff J, Altman DG PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41. doi: 10.1016/j.ijsu.2010.02.007. [DOI] [PubMed] [Google Scholar]
- 13.Loyo M, Tufano RP, Gourin CG. National Trends in Thyroid Surgery and the Effect of Volume on Short-term Outcomes. Laryngoscope. 2013;123:2056–63. doi: 10.1002/lary.23923. [DOI] [PubMed] [Google Scholar]
- 14.Lifante JC, Duclos A, Couray-Targe S, Colin C, Peix JL, Schott AM. Hospital volume influences the choice of operation for thyroid cancer. Brit J Surg. 2009;96:1284–8. doi: 10.1002/bjs.6741. [DOI] [PubMed] [Google Scholar]
- 15.Hauch A, Al-Qurayshi Z, Randolph Kandil E. Total Thyroidectomy is Associated with Increased Risk of Complications for Low- and High-Volume Surgeons. Ann Surg Oncol. 2014 doi: 10.1245/s10434-014-3846. [DOI] [PubMed] [Google Scholar]
- 16.Kandil E, Noureldine SI, Abbas A, Tufano RP. The impact of surgical volume on patient outcomes following thyroid surgery. Surgery. 2013;154(6):1346–53. doi: 10.1016/j.surg.2013.04.068. [DOI] [PubMed] [Google Scholar]
- 17.Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228:320–30. doi: 10.1097/00000658-199809000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mitchell J, Milas M, Barbosa G, Sutton J, Berber E, Siperstein A. Avoidable reoperations for thyroid and parathyroid surgery: Effect of hospital volume. Surgery. 2008;144(6):899–907. doi: 10.1016/j.surg.2008.07.022. [DOI] [PubMed] [Google Scholar]
- 19.Al-Qurayshi Z, Robins R, Hauch A, Randolph JW, Kandil E. Association with surgeons volume with outcomes and cost savings following thyroidectomies. A national forecast. JAMA Otolaryngol Head Neck Surg. 2016;142(1):32–9. doi: 10.1001/jamaoto.2015.2503. [DOI] [PubMed] [Google Scholar]
- 20.Adam MA, Thomas S, Youngwirth L, MD, Hyslop T, Reed SD, PhD, Scheri RP, Roman SA, Sosa JA. Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes? Ann Surg. 2016;20(10):1–6. doi: 10.1097/SLA.0000000000001688. [DOI] [PubMed] [Google Scholar]
- 21.Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57. doi: 10.1002/sim.3841. [DOI] [PubMed] [Google Scholar]
- 22.Meltzer C, Klau M, Gurushanthaiah D, Tsai J, Meng D, Radler L5 Sundang A. Surgeon Volume in Thyroid Surgery: Surgical Efficiency, Outcomes, and Utilization. The Laryngoscope. 2016 doi: 10.1002/lary.26119. [DOI] [PubMed] [Google Scholar]
- 23.Liang TJ, Liu SI, Mok KT, Shi HY. Associations of Volume and Thyroidectomy Outcomes: A Nationwide Study with Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2016;155(1):65–75. doi: 10.1177/0194599816634627. [DOI] [PubMed] [Google Scholar]
- 24.Nouraei SAR, Virk JS, Middleton SE, Aylin P, Mace A, Vaz F, Kaddour H, Darzi A, Tolley NS. A national analysis of trends, outcomes and volume-outcomes relationships in thyroid surgery. Clin Otolaryngol. 2017;42(2):354–365. doi: 10.1111/coa.12730. (2017) [DOI] [PubMed] [Google Scholar]
- 25.Dehal A, Abbas A, Al-Tememi M, Hussain F, Johna S. Impact of surgeon volume on incidence of neck hematoma after thyroid and parathyroid surgery: ten years’ analysis of nationwide inpatient sample database. Am Surg. 2014;80(10):948–52. [PubMed] [Google Scholar]
- 26.Adkisson CD, Howell GM, McCoy KL, Armstrong MJ, Kelley ML, Stang MT, Joyce JM, Hodak SP, Carty SE, Yip L. Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer. Surgery. 2014;156(6):1453–59. doi: 10.1016/j.surg.2014.08.024. [DOI] [PubMed] [Google Scholar]
- 27.González Sánchez C, Franch-Arcas G, Gómez Alonso A. Morbidity following thyroid surgery: does surgeon volume matter? Langenbek’s Arch Surg. 2013;398:419–22. doi: 10.1007/s00423-012-1027-4. [DOI] [PubMed] [Google Scholar]
- 28.Schuessler KM, Banerjee M, Yang D, Stewart AK, Doherty GM, Haymart MR. Surgeon training and use of radioactive Iodine in stage I thyroid cancer patients. Ann Surg Oncol. 2013;20(3):733–8. doi: 10.1245/s10434-012-2745-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.http//www.clubdelleuec.it
- 30.Abdulla AG, Ituarte PH, Harari A, Wu JX, Yeh MW. Trends in the Frequency and Quality of Parathyroid Surgery. Analysis of 17,082 Cases Over 10 Years. Ann Surg. 2015;261:746–50. doi: 10.1097/SLA.0000000000000812. [DOI] [PubMed] [Google Scholar]
- 31.Yeh MW, Wiseman JE, Chu SD, Ituarte PH, Liu IL, Young KL, Kang SJ, Harari A, Haigh PI. Population-level predictors of persistent hyperparathyroidism. Surgery. 2011;150:1113–9. doi: 10.1016/j.surg.2011.09.025. [DOI] [PubMed] [Google Scholar]
- 32.Scerrino G, Paladino NC, Di Paola V, Morfino G, Amodio E, Gulotta G, Bonventre S. The use of haemostatic agents in thyroid surgery: efficacy and further advantages. Collagen-Fibrinogen-Thrombin Patch (CFTP) versus Cellulose Gauze. Ann Ital Chir. 2013;84(5):545–50. [PubMed] [Google Scholar]
- 33.Romano G, Scerrino G, Profita G, Amato G, Salamone G, Di Buono G, Lo Piccolo C, Sorce V, Agrusa A, Gulotta G. Terminal or truncal ligation of the inferior thyroid artery during thyroidectomy? A prospective randomized trial. Int J Surg. 2016;28(Suppl 1):S13–6. doi: 10.1016/j.ijsu.2015.05.057. [DOI] [PubMed] [Google Scholar]
- 34.Scerrino G, Attard M, Lo Piccolo C, Attard A, Melfa GI, Raspanti C, Zarcone M, Bonventre S, Mazzola S, Gulotta G. The coexistence of primary hyperparathyroidism and thyroid nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted? G Chir. 2016;37(3):123–129. doi: 10.11138/gchir/2016.37.3.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Docimo G, Tolone S, Conzo G, Limongelli P, Del Genio G, Parmeggiani D, De Palma M, Lupone G, Avenia N, Lucchini R, Monacelli M, Gulotta G, Scerrino G, Pasquali D, Bellastella G, Esposito K, De Bellis A, Pezzolla A, Ruggiero R, Docimo L. A Gelatin-Thrombin Matrix Topical Hemostatic Agent (Floseal) in Combination With Harmonic Scalpel Is Effective in Patients Undergoing Total Thyroidectomy: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial. Surg Innov. 2016;23(1):23–9. doi: 10.1177/1553350615596638. [DOI] [PubMed] [Google Scholar]
- 36.Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017;69(2):161–169. doi: 10.1007/s13304-017-0447-7. [DOI] [PubMed] [Google Scholar]
- 37.Conzo G, Avenia N, Bellastella G, Candela G, de Bellis A, Esposito K, Pasquali D, Polistena A, Santini L, Sinisi AA. The role of surgery in the current management of differentiated thyroid cancer. Endocrine. 2014;47:380–388. doi: 10.1007/s12020-014-0251-9. [DOI] [PubMed] [Google Scholar]
- 38.Conzo G, Docimo G, Pasquali D, Mauriello C, Gambardella C, Esposito D, Tartaglia E, Della Pietra C, Napolitano S, Rizzuto A, Santini Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. BMC Surgery. 2013;13(Suppl 2):1–6. doi: 10.1186/1471-2482-13-S2-S3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Scerrino G, Paladino NC, Di Paola V, Morfino G, Inviati A, Amodio E, Gulotta G, Bonventre S. Minimally invasive video-assisted thyroidectomy: four-year experience of a single team in a General Surgery Unit. Minerva Chir. 2013;68(3):307–14. [PubMed] [Google Scholar]
- 40.Melfa GI, Raspanti C, Attard M, Cocorullo G, Attard A, Mazzola S, Salamone G, Gulotta G, Scerrino G. Comparison of minimally invasive parathyroidectomy under local anaesthesia and minimally invasive video-assisted parathyroidectomy for primary hyperparathyroidism: a cost analysis. G Chir. 2016;37(2):61–7. doi: 10.11138/gchir/2016.37.2.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Scerrino G, Castorina S, Melfa GI, Lo Piccolo C, Raspanti C, Richiusa P, Costa RP, Gulotta G. The intraoperative use of the mini-gamma camera (MGC) in the surgical treatment of primary hyperparathyroidism: Technical reports and immediate results from the initial experience. Ann Ital Chir. 2015;86(3):212–8. [PubMed] [Google Scholar]
- 42.Scerrino G, Paladino NC, Di Paola V, Morfino G, Matranga D, Gulotta G, Bonventre S. Total thyroidectomy performed with the Starion vessel sealing system versus the conventional technique: a prospective randomized trial. Surg Innov. 2010;17(3):242–7. doi: 10.1177/1553350610376394. [DOI] [PubMed] [Google Scholar]
- 43.Scerrino G, Inviati A, Di Giovanni S, Paladino NC, Di Paola V, Lo Re G, Almasio PL, Cupido F, Gulotta G, Bonventre S. Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results. Otolaryngol Head Neck Surg. 2013;148(6):926–32. doi: 10.1177/0194599813482299. [DOI] [PubMed] [Google Scholar]
- 44.Scerrino G, Inviati A, Di Giovanni S, Paladino NC, Di Giovanni S, Paladino NC, Di Paola V, Raspanti C, Melfa GI, Cupido F, Mazzola S, Porrello C, Bonventre S, Gulotta G. Long-term esophageal motility changes after thyroidectomy: associations with aerodigestive disorders. G Chir. 2017;37(5):193–9. doi: 10.11138/gchir/2016.37.5.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Scerrino G, Tudisca C, Bonventre S, Raspanti C, Picone D, Porrello C, Paladino NC, Vernuccio F, Cupido F, Cocorullo G, Lo Re G, Gulotta G. Swallowing disorders after thyroidectomy: What we know and where we are. A systematic review. Int J Surg. 2017;41(Suppl 1):S94–S102. doi: 10.1016/j.ijsu.2017.03.078. [DOI] [PubMed] [Google Scholar]
- 46.Scerrino G, Melfa G, Raspanti C, Attard A, Mazzola S, Gullo R, Bonventre S, Attard M, Cocorullo G, Gulotta G. The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbecks Arch Surg. 2017;402(7):1095–1102. doi: 10.1007/s00423-017-1568-7. [DOI] [PubMed] [Google Scholar]
- 47.Abdulla AG, Ituarte PH, Wiggins R, Teisberg EO, Harari A, Yeh MW. Endocrine surgery as a model for value-based health care delivery. Surg Neurol Int. 2012 doi: 10.4103/2152-7806.105102. [DOI] [PMC free article] [PubMed] [Google Scholar]